The Efficacy and Safety of Insulin Degludec/Liraglutide Combination (IDegLira) in Patients With Type 2 Diabetes
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 256 participants.
Also called NCT06408532
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 256 participants
- Registry
-
NCT06408532
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Not reported
- Registry status
- Unknown status
Technical summary
Registry record NCT06408532. Randomized; single masking; primary purpose treatment. Start 2024-04-30 (anticipated); primary completion 2024-10-30 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- The Efficacy and Safety of Insulin Degludec/Liraglutide Combination (IDegLira) in Patients With Type 2 Diabetes
- Condition
- Diabetes Mellitus, Type 2
- Intervention (Drug)
- IDegLira
- Intervention (Drug)
- Premixed insulin
- Lead sponsor
- Peking University People's Hospital
Record details
- Record id
cardio:ct-nct06408532- Content hash
56418c47d2ae3e49f05f1032320b01d210bef0465938d262615d8523d6bfc3a2